23Strands logo

23Strands

23Strands is unlocking the power of your DNA

29 employees · est. 2018 · Australia

VS
GenEmbryomics logo

GenEmbryomics

Genome sequencing of IVF embryos

6 employees · est. 2019 · San Francisco, United States

23Strands is the older company (2018 vs 2019); 23Strands is the larger of the two.

Side-by-Side Comparison

23Strands GenEmbryomics
Founded
2018 older 2019
Headquarters
Australia San Francisco, United States
Employees
29 larger 6
Industry
AI, Big Data, Biotechnology Biotechnology, Health Care, Life Sciences
Funding Stage
Seed Seed
Total Funding
$10.00K Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Whole Genome Sequencing, Genomic Health Analysis, Fertility23 Program, Medical Record Integration, Precision Health Insights, Concierge Health Pathway Not tracked yet
Target Customers
Clinicians, Healthcare Providers, Patients with Unexplained Infertility, Reproductive Health Specialists, Medical Researchers Not tracked yet
Taxonomy
Whole Human Genome Sequencing, Genomics, Integrated Medical Records, Health Improvements, Clinical Insights, Big Data Processing, Evidence-based Recommendations, Personalized Medicine, Disease Risk Assessment, Medication Optimization, Healthcare Innovation, Genetic Testing, DNA Analysis Not tracked yet
Website
23strands.com genembryomics.com
23Strands logo

About 23Strands

23Strands, with its slogan "23Strands is unlocking the power of your DNA," is an Australia-based startup leveraging advancements in AI, Big Data, Biotechnology, Health Care, and Machine Learning to innovate in the realm of genetic analysis. Founded in 2018, the company aims to redefine Whole Human...

GenEmbryomics logo

About GenEmbryomics

Yes, GenEmbryomics is a compelling biotech startup with a clear focus on revolutionizing genetic disease screening. The company, GenEmbryomics, founded in 2019 and headquartered in the United States, is gaining attention for its innovative approach to genome sequencing of IVF embryos. With the sloga...

We will tell you when either one moves

BounceWatch watches 23Strands and GenEmbryomics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at 23Strands and GenEmbryomics — by email.

Frequently Asked Questions

23Strands — 23Strands is unlocking the power of your DNA . GenEmbryomics — Genome sequencing of IVF embryos. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
23Strands has raised $10.00K while GenEmbryomics has raised undisclosed funding.
23Strands and GenEmbryomics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare 23Strands with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at 23Strands on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes